oseltamivir has been researched along with Pregnancy in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 20 (17.70) | 29.6817 |
2010's | 90 (79.65) | 24.3611 |
2020's | 3 (2.65) | 2.80 |
Authors | Studies |
---|---|
Balan, V; Blumberg, L; Cai, E; Cheng, V; Dagens, A; Dahmash, D; Groves, H; Harriss, E; Hart, P; Horby, PW; Jacob, S; Joseph, R; Lipworth, S; Michelen, M; Oti, A; Rigby, I; Sigfrid, L | 1 |
Chambers, CD; Johnson, D; Jones, KL; Luo, Y; Xu, R | 1 |
Kerr, SM; Mitchell, AA; Van Bennekom, CM | 1 |
Basavarajappa, M; Beland, FA; Fisher, J; Gamboa da Costa, G; Loukotková, L; Lumen, A; Mattison, D; Morris, SM; Roberts, R | 1 |
Botelho-Nevers, E; Cantais, A; Cizeron, A; Gagneux-Brunon, A; Pillet, S; Saunier, F | 1 |
Atreya, A; Gupta, J; Malhotra, B; Meena, BR; Meena, D; Sharma, P; Singh, R | 1 |
Avvari, S; Gollen, R; Jogiraju, VK; Taft, DR | 1 |
Chen, C; Chen, L; Guo, L; Guo, Q; Huang, JA; Mu, C; Wang, J; Xu, H | 1 |
Clinch, B; Ehrenstein, V; Kenwright, A; Kristensen, NR; Monz, BU; Sørensen, HT | 1 |
Belucci, TR; Dos Santos, OFP; Edmond, MB; Mafra, ACCN; Marra, AR; Pinho, JRR; Yokota, PKO | 1 |
Kubo, T; Minakami, H; Nakai, A; Saito, S; Unno, N; Yoshimura, Y | 1 |
Jurek, T; Kuchar, E; Rorat, M; Szenborn, L | 1 |
Jurek, T; Rorat, M | 1 |
Bao, C; Cui, L; Qi, X; Tang, F; Wang, H; Wu, B; Xu, K; Zhou, MH; Zhu, Y | 1 |
Beau, AB; Damase-Michel, C; Hurault-Delarue, C; Lacroix, I; Montastruc, JL; Vial, T | 1 |
Dunstan, HJ; Mill, AC; Stephens, S; Thomas, SH; Yates, LM | 1 |
Lutsevich, KA; Reshet'ko, OV; Sanina, II | 1 |
Ak, Ö; Alan, S; Aslan, T; Badur, S; Balkan, II; Benzonana, N; Ceylan, B; Ciblak, M; Dokucu, AI; Engin, D; Eraksoy, H; Ergönül, Ö; Fincancı, M; Gencer, S; Göktaş, P; Gulhan, E; Gündüz, A; Inan, A; Kantürk, A; Midilli, K; Nazlıcan, O; Öncül, O; Özer, S; Özgüneş, N; Ozyurt, M; Saltoğlu, N; Sargın, F; Şimşek, F; Uzun, N; Yazıcı, S; Yıldırmak, T | 1 |
Chandrasekaran, A; Tomianovic, D; Wollenhaupt, M | 1 |
Almirall, J; Blanquer, J; Canadell, L; Díaz, E; Grau, S; Martín-Loeches, I; Olona, M; Rodriguez, A; Sureda, F; Trefler, S; Yebenes, JC | 1 |
Beigi, RH; Caritis, SN; Venkataramanan, R | 1 |
Born, Pda S; Carney, S; Magalhães, V; Mello, WA; Mesquita, M; Motta, Fdo C; Oliveira, Mde L; Oliveira, MJ; Resende, PC; Siqueira, MM; Souza, TM | 1 |
Birnkrant, DB; Chan-Tack, KM; Kim, C; Moruf, A | 1 |
Chan, JD; Chu, HY; Dellit, TH; Englund, JA; Huang, D; Jain, R; Jerome, KR; Kuypers, J; Lynch, JB; Pottinger, PS; Scott, E | 1 |
Beigi, RH; Caritis, SN; Clark, S; Easterling, TR; Han, K; Hankins, GD; Hebert, MF; Pillai, VC; Ren, Z; Venkataramanan, R; Zajicek, A | 1 |
Beigi, RH; Caritis, SN; Pillai, VC; Venkataramanan, R | 1 |
Azziz-Baumgartner, E; Blanco, N; Bonilla, L; Chacon, R; Clara, WA; Guzman, G; Jara, J; Minaya, P; Mirza, S; Moreno, L; Palekar, R; Paredes, A; Rodriguez, D; Then, CJ | 1 |
Chang, CC; Chen, PH; Shih, YL | 1 |
Agarwal, S; Agrawal, A; Chejara, R; Kumar, V; Mital, P; Nawal, CL | 1 |
Alame, MM; Ghulmiyyah, LM; Mirza, FG; Nassar, AH; Zaraket, H | 1 |
Andrews, WW; Tita, AT | 1 |
Duan, J; Huang, H; Li, Q; Tian, Y; Wang, J; Wu, D; Yao, Q; Zhang, J; Zheng, Q; Zhou, Q | 1 |
Brennan, M; Clooney, L; Coughlan, S; Drew, RJ; Eogan, M; Griffin, J; LeBlanc, D; Linehan, E; O'Rourke, S | 1 |
Chidiac, C | 1 |
Bawdon, RE; Roberts, SW; Worley, KC | 1 |
Bresee, JS; Broder, K; Cox, NS; Fiore, AE; Iskander, JK; Mootrey, G; Shay, DK; Uyeki, TM | 1 |
de Jong, MD | 1 |
Anh, GT; Bien, NM; Binh, NG; Chau, NQ; Crusat, M; Day, N; de Jong, MD; Farrar, JJ; Fox, A; Ha, NH; Hanh, TT; Hien, ND; Horby, P; Lien, TT; Lindegardh, N; Ngoc, NM; Stepniewska, K; Taylor, WR; Thinh, BN; Trung, NV; Wertheim, H; White, NJ | 1 |
Garcia-Bournissen, F; Ito, S; Koren, G; Murashima, A; Nakajima, K; Tanaka, T | 1 |
Albert, P; Alvarez-Lerma, F; Avellanas, M; Cebrian, J; Del Nogal-Saez, F; Ferrer, M; Galván, B; Granada, R; Guerrero, J; Ibañez, P; León-Gil, C; Maraví-Poma, E; Marques, A; Marquez, E; Martínez, S; Ortiz, P; Prieto del Portillo, I; Rello, J; Rodríguez, A; Ruiz-Santana, S; Sierra, R; Socias, L; Vidaur, L | 1 |
Burioni, R; Canducci, F; Clementi, M | 1 |
Biswas, A; Chan, J; Chong, YS; Choolani, M; Su, LL; Yong, EL | 1 |
Ami, O; Donnadieu, AC; Dupont-Bernabé, C; Fernandez, H; Frydman, R; Guillet, M; Martinez, V; Picone, O; Senat, MV; Trichot, C; Vauloup-Fellous, C | 1 |
Bryant, A; Chapman, J; Morse, J; Saleeby, E | 1 |
Akalin, E; Chapochnick-Friedmann, J; Lu, A; Marfo, K | 1 |
Clardy, BH; Payne, EM; Spradlin, TL; Vinson, J | 1 |
Albaya-Moreno, A; Algora-Weber, A; Balasini, C; Barahona, D; Figueira, JC; González, N; Guerrero, JE; León-Gil, C; Lisboa, T; Lorente, L; Maraví-Poma, E; Martín, M; Pérez-Padilla, R; Rello, J; Rodríguez, A; Socías, L; Vallés, J; Villabón, M | 1 |
Bozzo, P; Djokanovic, N; Koren, G | 1 |
Brown, CM | 1 |
Changpinyo, M; Dulyachai, W; Kitikoon, P; Makkoch, J; Payungporn, S; Poovorawan, Y; Prayangprecha, S; Rianthavorn, P; Tantilertcharoen, R | 1 |
Chee, JJ; Chong, CY; Lim, ML; Lim, WY; Tee, WS | 1 |
Bouscambert-Duchamp, M; Escuret, V; Ferraris, O; Lina, B; Morfin, F | 1 |
Greer, LG; McIntire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD | 1 |
Haas, W | 1 |
Bender, M; Bernheisel, C | 1 |
Dembinski, J | 1 |
Lecumberri, J; Montané, E; Pedro-Botet, ML | 1 |
Chee, JJ; Lim, ML; Lim, SH; Lim, WY; Tee, NW | 1 |
Avery, L; Kumar, A; Lapinsky, S; Menticoglou, S; Oluyomi-Obi, T; Schneider, C; Zarychanski, R | 1 |
Lu, H; Shen, Y | 1 |
Akyüz, S; Bülbül, M; Demircin, G; Erdogan, O; Renda, R; Yilmaz, A | 1 |
Berkovitch, M; Karplus, R; Sanset, S; Schneider, D; Zaidenstein, R | 1 |
Brocklehurst, P; Knight, M; Kurinczuk, JJ; Mill, AC; Pierce, M; Spark, P; Stephens, S; Thomas, SH; Valappil, M; Yates, L | 1 |
Donner, B; Hoffmann, G; Niranjan, V | 1 |
Buettner, PG; Burgher, B; Dixit, R; Egan, A; Francis, F; Grewal, A; Harris, PN; Jayalath, R; Leahy, C; Norton, RE; Proud, M | 1 |
Chan, KH; Hung, IF; Li, IW; To, KK; Tse, H; Wong, SS; Woo, PC; Yuen, KY | 1 |
Tsukahara, Y | 1 |
Allenet, B; Bussières, JF; Ferreira, E; Skalli, S | 1 |
Isaacs, D | 1 |
Danisman, N; Dilmen, U; Erdeve, O; Kanmaz, HG; Mollamahmutoglu, L; Oguz, SS; Unlu, S; Uras, N | 1 |
Abdel-Rahman, SM; Kearns, GL; Newland, JG | 1 |
Feng, L; Feng, Y; Feng, Z; Gao, Z; Gargiullo, P; Huai, Y; Jiang, H; Liao, Q; Peng, Z; Shu, Y; Uyeki, TM; Wang, Y; Xiang, N; Xu, C; Yang, W; Ye, M; Yu, H; Yuan, Y; Zhang, Y; Zheng, J; Zheng, Y; Zhou, L | 1 |
Jamieson, DJ; Louie, JK; Norman, A; Wadford, DA | 1 |
Khadse, S; Kinikar, A; Kulkarni, R; Valvi, C | 1 |
Aldunate, S; Almirall, J; Arenzana, A; Arnau, E; Bermejo-Martin, JF; Cambra, K; Gonzalez, N; Guerrero, JE; Laplaza, C; Lorente, L; Loza-Vazquez, A; Magret, M; Maraví-Poma, E; Marquez, E; Martin-Loeches, I; Regidor, E; Reig Valero, R; Rello, J | 1 |
Chambers, CD; Jones, KL; Louik, C; Mitchell, AA; Schatz, M | 1 |
Goldfarb, I; Panda, B; Riley, L; Wylie, B | 1 |
Benachi, A; Bernabe-Dupont, C; Boileau, P; Castel, C; Cordier, AG; Frydman, R; Grangeot-Keros, L; Guillet, M; Picone, O; Vauloup-Fellous, C | 1 |
Bellissima, G; Bellissima, P | 1 |
Greer, LG; Leff, RD; McCracken, GH; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD | 1 |
Beigi, RH; Caritis, SN; Clark, S; Easterling, T; Han, K; Hankins, GD; Hebert, MF; Mattison, DR; Ren, Z; Venkataramanan, R; Zajicek, A | 1 |
Anderson, BL; Fitzsimmons, C; Rouse, DJ | 1 |
Clarke, D; Mirochnick, M | 1 |
Bowkalow, S; Brauer, M; Gross, W; Schleussner, E | 1 |
Godara, SM; Goplani, KR; Kute, V; Shah, PR; Trivedii, HL; Vanikar, AV | 1 |
Adiga, RB; Alsup, R; Clay, PG; Gerk, PM; McRae, M; Taylor, TAH | 1 |
Granath, F; Kieler, H; Stephansson, O; Svensson, T | 1 |
Beauloye, C; Courouble, P; Geukens, P; Jacquet, LM; Laarbaui, F; Van Caenegem, O | 1 |
Itabashi, K; Kitajima, H; Kusuda, S; Morioka, I; Takahashi, N | 1 |
Berveiller, P; Bonati, C; Duchene, P; Gil, S; Giraud, C; Mir, O; Treluyer, JM; Vinot, C | 1 |
Calvo Aguilar, O; Canalizo Mendoza, YR; Hernández Cuevas, MJ | 1 |
Arnold, K; Baumbach, J; Bennett, NM; Doshi, S; Finelli, L; Fry, AM; Gershman, K; Hancock, EB; Kamimoto, L; Lynfield, R; Morin, C; Perez, A; Reingold, A; Ryan, P; Schaffner, W; Thomas, A; Yousey-Hindes, K; Zansky, S | 1 |
Breda, I; Coelho, LR; De Souza, BA; Figueiró-Filho, EA; Oliveira, ML; Pompilio, MA; Uehara, SN | 1 |
Carratalá, J; Fariñas, MC; García-Gasalla, M; Leyes, M; López-Medrano, F; Martínez-Sánchez, N; Ortega, L; Oteo, JA; Pachón, J; Paño-Pardo, JR; Pumarola, T; Rodríguez-Baño, J; Segura, F; Torre-Cisneros, J; Viasus, D | 1 |
Lenzi, L; Pontarolo, R | 1 |
Amr, AA; Kherallah, M; Mady, A; Mandourah, Y; Ramadan, OS; Yousef, A | 1 |
Bruinse, HW; Kromdijk, W; Meijer, WJ; van den Broek, MP; Wensing, AM | 1 |
Hou, GQ; Huang, CS; Kuo, TC; Li, YT; Lin, CH; Tasi, SJ | 1 |
Ahmed, MS; Hankins, GD; Nanovskaya, TN; Patrikeeva, S; Zhan, Y | 1 |
Lin, CC; Lin, LC; Tsai, TH; Wu, YT; Yen, JC | 1 |
Ersbøll, AS; Hedegaard, M; Hesselvig, AB; Krebs, L | 1 |
Cantu, J; Tita, AT | 1 |
Fell, DB; Liu, N; Smith, GN; Sprague, AE; Walker, MC; Wen, SW; Xie, HY; Xie, RH; Yasseen, AS | 1 |
Monto, AS; Whitley, RJ | 1 |
18 review(s) available for oseltamivir and Pregnancy
Article | Year |
---|---|
Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines.
Topics: Aged; Antiviral Agents; Child; Child, Preschool; COVID-19; Female; Humans; Influenza, Human; Oseltamivir; Pandemics; Pregnancy | 2022 |
[Peculiarities and clinical significance of drug pharmacokinetics and pharmacodynamics during pregnancy].
Topics: Antiviral Agents; Biological Availability; Biotransformation; Blood Proteins; Carrier Proteins; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Models, Statistical; Oseltamivir; Pregnancy; Protein Binding | 2014 |
The safety of oseltamivir in pregnancy: an updated review of post-marketing data.
Topics: Antiviral Agents; Databases, Factual; Embryonic Development; Female; Fetal Development; Humans; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Product Surveillance, Postmarketing | 2014 |
Oseltamivir for influenza in pregnancy.
Topics: Antiviral Agents; Female; Humans; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious | 2014 |
Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Investigational New Drug Application; Male; Middle Aged; Oseltamivir; Pregnancy; Retrospective Studies; United States; Young Adult; Zanamivir | 2015 |
Oseltamivir for the treatment of H1N1 influenza during pregnancy.
Topics: Animals; Antiviral Agents; Enzyme Inhibitors; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Risk Assessment; Risk Factors; Treatment Outcome | 2015 |
Influenza and its treatment during pregnancy: A review.
Topics: Animals; Antiviral Agents; Female; Humans; Influenza Vaccines; Influenza, Human; Membrane Transport Proteins; Oseltamivir; Post-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Vaccination; Zanamivir | 2015 |
[Influenza].
Topics: Adolescent; Adult; Age Factors; Aged; Amantadine; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Diagnosis, Differential; Female; Follow-Up Studies; France; Humans; Infant; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Seasons; Time Factors; Treatment Outcome; Zanamivir | 2008 |
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
Topics: Breast Feeding; Enzyme Inhibitors; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactation; Neuraminidase; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Vaccines; Zanamivir | 2009 |
[Pandemic influenza A H1N1 2009 flu during pregnancy: Epidemiology, diagnosis and management].
Topics: Antiviral Agents; Disease Outbreaks; Female; France; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Nasopharynx; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Zanamivir | 2009 |
[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Topics: Adult; Antiviral Agents; Child; Clinical Trials as Topic; Disease Outbreaks; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Influenza A virus; Influenza, Human; Male; Models, Molecular; Molecular Structure; Mutation, Missense; Neuraminidase; Oseltamivir; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Protein Conformation; Viral Proteins; Zanamivir | 2010 |
[Influenza A, pregnancy and neuraminidase inhibitors].
Topics: Animals; Antiviral Agents; Australia; Centers for Disease Control and Prevention, U.S.; Drug Evaluation, Preclinical; Drug Utilization; Europe; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neuraminidase; New Zealand; Oseltamivir; Pandemics; Practice Guidelines as Topic; Pregnancy; Pregnancy Outcome; Risk Assessment; United States; Viral Proteins; World Health Organization; Zanamivir | 2011 |
Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.
Topics: Animals; Antiviral Agents; Drug Evaluation, Preclinical; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects | 2010 |
[Change of strategies for novel and seasonal flu during pregnancy].
Topics: Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Zanamivir | 2010 |
[Influenza A/H1N1v 2009 during pregnancy and breastfeeding: which antiviral to choose?].
Topics: Adult; Antiviral Agents; Breast Feeding; Female; Fetus; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Zanamivir | 2010 |
Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.
Topics: Adult; Age Factors; Animals; Antiviral Agents; Biological Availability; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Prodrugs | 2011 |
Antiviral drugs for influenza.
Topics: Adult; Amantadine; Antiviral Agents; Child; Female; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Rimantadine; Zanamivir | 2012 |
Management of influenza in pregnancy.
Topics: Antiviral Agents; Female; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Isolation; Pregnancy; Pregnancy Complications, Infectious; Zanamivir | 2013 |
2 trial(s) available for oseltamivir and Pregnancy
Article | Year |
---|---|
Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women.
Topics: Adolescent; Adult; Antiviral Agents; Computer Simulation; Female; Humans; Middle Aged; Models, Biological; Oseltamivir; Pregnancy; Young Adult | 2015 |
Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Female; Hemofiltration; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Intubation, Gastrointestinal; Male; Oseltamivir; Pregnancy; Respiration, Artificial; Treatment Outcome; Viral Load | 2008 |
93 other study(ies) available for oseltamivir and Pregnancy
Article | Year |
---|---|
Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants.
Topics: Adult; Antiviral Agents; Case-Control Studies; Congenital Abnormalities; Female; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Influenza A Virus, H1N1 Subtype; Influenza, Human; Odds Ratio; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Prenatal Exposure Delayed Effects; Prospective Studies; Risk; Young Adult | 2019 |
Oseltamivir exposure in pregnancy and the risk of specific birth defects.
Topics: Adult; Case-Control Studies; Congenital Abnormalities; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Odds Ratio; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Young Adult | 2019 |
Pharmacokinetics of oseltamivir phosphate and oseltamivir carboxylate in non-pregnant and pregnant rhesus monkeys.
Topics: Animals; Antiviral Agents; Dose-Response Relationship, Drug; Female; Injections, Intravenous; Intubation, Gastrointestinal; Macaca mulatta; Molecular Conformation; Oseltamivir; Phosphorous Acids; Pregnancy | 2020 |
Low rate of oseltamivir prescription among adults and children with confirmed influenza illness in France during the 2018-19 influenza season.
Topics: Adult; Antiviral Agents; Child; Enzyme Inhibitors; Female; France; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Prescriptions; Prospective Studies; Seasons; Zanamivir | 2021 |
Epidemiological & clinical profile of influenza A (H1N1) 2009 virus infections during 2015 epidemic in Rajasthan.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Disease Outbreaks; Female; Humans; India; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Oseltamivir; Pregnancy; Risk Factors; Young Adult | 2016 |
Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.
Topics: Adult; Computer Simulation; Female; Humans; Metformin; Middle Aged; Models, Biological; Oseltamivir; Pregnancy; Reproducibility of Results; Tacrolimus; Young Adult | 2017 |
A study on mother-to-fetus/infant transmission of influenza A(H7N9) virus: Two case reports and a review of literature.
Topics: Acids, Carbocyclic; Adult; Cyclopentanes; Enzyme Inhibitors; Fatal Outcome; Female; Fetal Death; Fetus; Guanidines; Humans; Infant; Influenza A Virus, H7N9 Subtype; Influenza, Human; Maternal-Fetal Exchange; Mothers; Neuraminidase; Oseltamivir; Pregnancy; Secondary Prevention; Treatment Outcome | 2018 |
ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza.
Topics: Antiviral Agents; Chemoprevention; Female; Humans; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious | 2018 |
Oseltamivir in pregnancy and birth outcomes.
Topics: Adult; Congenital Abnormalities; Denmark; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Prenatal Exposure Delayed Effects; Registries; Young Adult | 2018 |
Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Brazil; Case-Control Studies; Drug Utilization Review; Female; Hospital Mortality; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pregnancy; Risk Factors; Tertiary Care Centers | 2018 |
Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antiviral Agents; Female; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Time Factors; Zanamivir | 2013 |
The clinical course of late diagnosed fatal cases of A (H1N1) influenza in Poland.
Topics: Adult; Age of Onset; Aged; Antiviral Agents; Arthritis; Cause of Death; Coinfection; Comorbidity; Cross Infection; Delayed Diagnosis; Disease Progression; Fatty Liver; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia; Poland; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Survival Rate; Young Adult | 2013 |
Adverse event analysis in fatal cases of influenza A (H1N1) - a lesson from Poland.
Topics: Adult; Antiviral Agents; Arthritis; Delayed Diagnosis; Diagnostic Errors; Female; Hospitalization; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Office Visits; Oseltamivir; Pandemics; Poland; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Time-to-Treatment; Young Adult | 2013 |
Avian influenza A(H7N9) virus infection in pregnant woman, China, 2013.
Topics: Antiviral Agents; China; Female; Fetus; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Molecular Typing; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Reassortant Viruses; Viral Proteins | 2014 |
Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database.
Topics: Adult; Antiviral Agents; Cohort Studies; Databases, Factual; Female; Humans; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome | 2014 |
Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study.
Topics: Adolescent; Adult; Antiviral Agents; Epidemiological Monitoring; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; United Kingdom; Young Adult; Zanamivir | 2014 |
Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults.
Topics: Adult; Antiviral Agents; Cross Infection; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Neuraminidase; Odds Ratio; Oseltamivir; Pregnancy; Turkey; Zanamivir | 2014 |
Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
Topics: Adult; Aged; Antiviral Agents; APACHE; Cohort Studies; Comorbidity; Critical Care; Drug Utilization; Female; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Medication Adherence; Middle Aged; Oseltamivir; Pandemics; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Registries; Spain; Survival Rate | 2015 |
Molecular findings from influenza A(H1N1)pdm09 detected in patients from a Brazilian equatorial region during the pandemic period.
Topics: Antiviral Agents; Biomarkers; Brazil; Drug Resistance, Viral; Female; Gene Frequency; Hemagglutinins; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Pandemics; Phylogeny; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Virulence; Virulence Factors | 2014 |
Impact of rapid influenza PCR testing on hospitalization and antiviral use: A retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hospitalization; Humans; Influenza, Human; Male; Middle Aged; Molecular Diagnostic Techniques; Oseltamivir; Polymerase Chain Reaction; Pregnancy; Retrospective Studies; Time Factors; Young Adult | 2015 |
Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009-2010.
Topics: Adolescent; Adult; Antiviral Agents; Asthma; Central America; Comorbidity; Costa Rica; Disease Outbreaks; Dominican Republic; El Salvador; Female; Fever; Guatemala; Honduras; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nicaragua; Oseltamivir; Pregnancy; Pulmonary Disease, Chronic Obstructive; Young Adult | 2015 |
[Haut Conseil de la Santé Publique (HCSP). Guidance on the prioritization of antiviral drugs in case of seasonal influenza epidemics (March 3, 2015)].
Topics: Adult; Age Factors; Aged; Antiviral Agents; Child; Comorbidity; Disease Management; Disease Susceptibility; Drug Utilization; Epidemics; Female; France; Humans; Influenza Vaccines; Influenza, Human; Male; Meta-Analysis as Topic; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Seasons; Vulnerable Populations; Zanamivir | 2015 |
Successful management of atypical pneumonia in acute respiratory distress syndrome patient during pregnancy.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Ceftriaxone; Cesarean Section; Female; Fetal Monitoring; Humans; Lung; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia; Pregnancy; Pregnancy Complications; Radiography; Respiratory Distress Syndrome | 2015 |
A study of an influenza A (H1N1)pdm09 outbreak in pregnant women in Rajasthan, India.
Topics: Adult; Antiviral Agents; Disease Outbreaks; Female; Hospitalization; Humans; India; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tertiary Care Centers; Time-to-Treatment; Vaccination | 2016 |
Influenza Vaccination and Antiviral Therapy in Pregnant Women.
Topics: Antiviral Agents; Female; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Vaccination | 2016 |
Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population.
Topics: Antiviral Agents; Case-Control Studies; China; Female; Fetus; Humans; Influenza, Human; Maternal-Fetal Exchange; Oseltamivir; Perfusion; Placenta; Pregnancy | 2017 |
Impact of introduction of xpert flu assay for influenza PCR testing on obstetric patients: a quality improvement project.
Topics: Adult; Antiviral Agents; Female; Hospitals, Maternity; Humans; Influenza, Human; Oseltamivir; Patient Admission; Point-of-Care Systems; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Quality Improvement | 2018 |
The metabolism and transplacental transfer of oseltamivir in the ex vivo human model.
Topics: Antipyrine; Antiviral Agents; Female; Fetus; Humans; Maternal-Fetal Exchange; Models, Biological; Oseltamivir; Perfusion; Placenta; Pregnancy | 2008 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Oseltamivir; Pregnancy; Seasons; United States; Zanamivir | 2008 |
Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Canada; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Zanamivir | 2008 |
H5N1 transmission and disease: observations from the frontlines.
Topics: Animals; Antiviral Agents; Cytokines; Female; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Male; Oseltamivir; Pregnancy; Receptors, Cell Surface; Receptors, Virus; Viral Load; Virus Replication | 2008 |
Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009.
Topics: Adult; Antiviral Agents; Fatal Outcome; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain.
Topics: Adult; Antiviral Agents; Critical Care; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Medical Audit; Middle Aged; Mutation; Oseltamivir; Pregnancy; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Severity of Illness Index; Spain | 2009 |
Pregnancy and H1N1 infection.
Topics: Antibodies, Monoclonal; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; United States | 2009 |
Pregnancy and H1N1 infection.
Topics: Antiviral Agents; Early Diagnosis; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Singapore; Time Factors; Treatment Outcome | 2009 |
H1N1 influenza in pregnancy: cause for concern.
Topics: Adult; Antiviral Agents; Fatal Outcome; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Reagent Kits, Diagnostic | 2009 |
Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antiviral Agents; Cesarean Section; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Medical History Taking; Oseltamivir; Pregnancy; Renal Dialysis; Risk Factors; Rituximab; Siblings; Treatment Outcome | 2009 |
H1N1 influenza in pregnancy: cause for concern.
Topics: Antiviral Agents; Compassionate Use Trials; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Zanamivir | 2010 |
[Pandemic influenza A in the ICU: experience in Spain and Latin America. GETGAG/SEMICYUC/(Spanish Working Group on Severe Pandemic Influenza A/SEMICYUC)].
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Comorbidity; Disease Outbreaks; Female; Hospital Mortality; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Latin America; Male; Middle Aged; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Registries; Respiration, Artificial; Respiratory Insufficiency; Severity of Illness Index; Shock; Spain; Young Adult | 2010 |
H1N1 influenza in pregnancy: risks, vaccines, and antivirals.
Topics: Antiviral Agents; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zanamivir | 2009 |
Severe influenza A virus (H1N1) infection in pregnancy.
Topics: Adult; Antiviral Agents; Cesarean Section; Female; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Respiration, Artificial; Respiratory Distress Syndrome | 2010 |
Perinatal pandemic (H1N1) 2009 infection, Thailand.
Topics: Antiviral Agents; Disease Outbreaks; Female; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Thailand | 2010 |
Influenza A/H1N1 (2009) infection in pregnancy--an Asian perspective.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Cohort Studies; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prospective Studies; Singapore; Time Factors; Young Adult; Zanamivir | 2010 |
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
Topics: Amantadine; Antiviral Agents; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rimantadine | 2010 |
[Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].
Topics: Adolescent; Adult; Age Factors; Antiviral Agents; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Infant; Influenza A virus; Influenza, Human; Male; Meta-Analysis as Topic; Middle Aged; Neuraminidase; Oseltamivir; Pregnancy; Risk Factors; Seasons; Zanamivir | 2010 |
Fever, cough, and hypoxia in a pregnant woman.
Topics: Adult; Antiviral Agents; Cough; Female; Fever; Humans; Hypoxia; Influenza A Virus, H1N1 Subtype; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Vomiting | 2010 |
[Oseltamivir in pregnancy, lactation and neonatal period--comparison of international recommendations].
Topics: Female; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactation; Oseltamivir; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious | 2010 |
Obstetric outcomes of influenza A H1N1 (2009) infection in pregnancy--experience of a Singapore tertiary hospital.
Topics: Adolescent; Adult; Antiviral Agents; Apgar Score; Birth Weight; Female; Gestational Age; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Obstetrics and Gynecology Department, Hospital; Oseltamivir; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications; Singapore; Young Adult | 2010 |
Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antiviral Agents; Critical Illness; Disease Outbreaks; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Manitoba; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Respiration, Artificial | 2010 |
Pandemic (H1N1) 2009, Shanghai, China.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; China; Disease Outbreaks; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; RNA, Viral; Time Factors; Travel | 2010 |
Do immunosupressive patients really have a severe outcome with H1N1 virus infection?
Topics: Antiviral Agents; Child; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Risk Factors; Treatment Outcome | 2011 |
Suspected oseltamivir-induced bradycardia.
Topics: Adult; Antiviral Agents; Bradycardia; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2010 |
Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
Topics: Adolescent; Adult; Antiviral Agents; Female; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Prospective Studies; Risk Factors; United Kingdom; Young Adult | 2010 |
Pandemic influenza H1N1 2009 in north Queensland--risk factors for admission in a region with a large indigenous population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Critical Care; Disease Notification; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Oseltamivir; Pregnancy; Queensland; Risk Factors; Young Adult | 2010 |
Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Obesity; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Seasons; Treatment Outcome; Young Adult | 2010 |
Lessons from the swine flu: pandemic, panic and/or pandemonium?
Topics: Antiviral Agents; Australia; Child; Disease Outbreaks; Emergency Medical Services; Female; Global Health; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Seizures, Febrile; Young Adult | 2010 |
Dealing with pandemic influenza A during postpartum and early neonatal period in a busy family-centered neonatal intensive care unit.
Topics: Antiviral Agents; Family Nursing; Female; Hospitalization; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Intensive Care Units, Neonatal; Oseltamivir; Pandemics; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies | 2011 |
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; China; Chronic Disease; Female; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Obesity; Oseltamivir; Pregnancy; Risk Factors; Young Adult | 2011 |
2009 pandemic influenza A (H1N1) and vaccine failure in pregnancy.
Topics: Adult; Antiviral Agents; Cesarean Section; Female; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Respiration, Artificial; Respiratory Distress Syndrome; Treatment Failure | 2011 |
2009H1N1 Infection in a 1-day-old neonate.
Topics: Anesthesia, Obstetrical; Antiviral Agents; Cesarean Section; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Influenza A Virus, H1N2 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2010 |
Severe 2009 A/H1N1v influenza in pregnant women in Spain.
Topics: Adolescent; Adult; Age Distribution; Antiviral Agents; Communicable Disease Control; Confidence Intervals; Critical Care; Female; Hospitalization; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Linear Models; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Spain; Statistics, Nonparametric; Survival Rate; Young Adult | 2011 |
Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.
Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Case-Control Studies; Congenital Abnormalities; Female; Humans; Immunization; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Prospective Studies; Risk Assessment; Societies, Medical; United States; Zanamivir | 2011 |
Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.
Topics: Antiviral Agents; Female; Health Knowledge, Attitudes, Practice; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Massachusetts; Oseltamivir; Pandemics; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Safety; Seasons; Treatment Refusal; Vaccination | 2011 |
[A suspected case of in utero transmission of influenza A (H1N1) 2009].
Topics: Adult; Antiviral Agents; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Nasopharynx; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious | 2011 |
[Pulmonary complications from pandemic AH1N1 influenza: clinical-radiological features].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Pharmacokinetics of oseltamivir according to trimester of pregnancy.
Topics: Adolescent; Adult; Antiviral Agents; Area Under Curve; Female; Half-Life; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Maximum Allowable Concentration; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Time Factors; Young Adult | 2011 |
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antiviral Agents; Area Under Curve; Case-Control Studies; Female; Humans; Influenza, Human; Metabolic Clearance Rate; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2011 |
Clinical characteristics of pregnant women with influenza-like illness during the 2009 H1N1 pandemic and use of a standardized management algorithm.
Topics: Adolescent; Adult; Algorithms; Ambulatory Care; Antiviral Agents; Body Temperature; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Treatment Outcome; United States; Young Adult | 2011 |
Oseltamivir pharmacokinetics in pregnancy: a commentary.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Biomedical Research; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Research Design | 2011 |
Severe H1N1-infection during pregnancy.
Topics: Abortion, Spontaneous; Antiviral Agents; Extracorporeal Membrane Oxygenation; Fatal Outcome; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Respiration, Artificial; Severity of Illness Index; Young Adult; Zanamivir | 2011 |
Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction.
Topics: Adult; Antiviral Agents; Drug Interactions; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Oseltamivir; Postoperative Complications; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Homologous; Treatment Outcome | 2011 |
Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza.
Topics: Acids, Carbocyclic; Adult; Antiviral Agents; Cesarean Section; Cyclopentanes; Disease Outbreaks; Female; Guanidines; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Severity of Illness Index; Treatment Outcome | 2011 |
Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
Topics: Adult; Antiviral Agents; Cohort Studies; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Influenza, Human; Male; Maternal Age; Maternal-Fetal Exchange; Neuraminidase; Oseltamivir; Parity; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Risk Factors; Young Adult; Zanamivir | 2011 |
Adult respiratory distress syndrome caused by 2009 H1N1 influenza during pregnancy: success of ECMO for both the mother and the child.
Topics: Antiviral Agents; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Treatment Outcome | 2011 |
Pandemic (H1N1) 2009 in neonates, Japan.
Topics: Antiviral Agents; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious | 2011 |
Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model.
Topics: Antiviral Agents; Female; Fetus; Humans; Maternal-Fetal Exchange; Oseltamivir; Placenta; Pregnancy; Prodrugs | 2012 |
[Influenza H1N1 in obstetric population of a general hospital in Oaxaca].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antiviral Agents; Combined Modality Therapy; Female; Hospitals, General; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mexico; Oseltamivir; Pandemics; Pneumonia, Viral; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Respiration, Artificial; Retrospective Studies; Water-Electrolyte Imbalance; Young Adult | 2011 |
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Guideline Adherence; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Rimantadine; United States; Young Adult; Zanamivir | 2011 |
Obstetric, clinical, and perinatal implications of H1N1 viral infection during pregnancy.
Topics: Adolescent; Adult; Antiviral Agents; Brazil; Cross-Sectional Studies; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Maternal Mortality; Oseltamivir; Pandemics; Perinatal Mortality; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Treatment Outcome; Young Adult | 2012 |
Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy.
Topics: Adolescent; Adult; Antiviral Agents; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Spain; Young Adult | 2012 |
Evaluation of pregnancy as a risk factor in the outcomes of influenza A (H1N1)/2009 in women of childbearing age.
Topics: Adolescent; Adult; Age Factors; Antiviral Agents; Brazil; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; Risk Factors; Young Adult | 2012 |
Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia.
Topics: Adolescent; Adult; Aged; Antiviral Agents; APACHE; Child; Child, Preschool; Female; Hospital Mortality; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Oseltamivir; Pregnancy; Retrospective Studies; Risk Factors; Saudi Arabia; Young Adult | 2012 |
Oseltamivir and its active metabolite cross the placenta at significant levels.
Topics: Adult; Antiviral Agents; Chromatography, Liquid; Female; Fetal Blood; Humans; Influenza, Human; Oseltamivir; Placenta; Plasma; Pregnancy; Pregnancy Complications, Infectious; Tandem Mass Spectrometry | 2012 |
Severe 2009 H1N1 infection in early pregnancy.
Topics: Abortion, Induced; Acyclovir; Adult; Antiviral Agents; Disseminated Intravascular Coagulation; Female; Herpes Genitalis; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Valacyclovir; Valine; Young Adult | 2012 |
Transplacental transfer of oseltamivir carboxylate.
Topics: Antiviral Agents; Biological Transport; Cells, Cultured; Diffusion; Female; Humans; Maternal-Fetal Exchange; Organ Culture Techniques; Oseltamivir; Perfusion; Placenta; Pregnancy; Term Birth; Tissue Distribution | 2012 |
Chemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant rats.
Topics: Amniotic Fluid; Animals; Antiviral Agents; Area Under Curve; Chromatography, Liquid; Female; Fetus; Humans; Maternal-Fetal Exchange; Models, Biological; Oseltamivir; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2012 |
[Report: complicated influenza A(H1N1) in a second-trimester pregnancy].
Topics: Adult; Antibiotic Prophylaxis; Antiviral Agents; Cesarean Section; Female; Humans; Infant, Extremely Premature; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Radiography; Risk Factors | 2012 |
Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic.
Topics: Adult; Antiviral Agents; Apgar Score; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Retrospective Studies; Young Adult | 2013 |
Influenza prevention 2002-2003.
Topics: Acetamides; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanidines; Headache; Humans; Infant; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Pyrans; Sialic Acids; Zanamivir | 2002 |
Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement.
Topics: Acetamides; Adolescent; Age Factors; Amantadine; Animals; Antiviral Agents; Canada; Child; Child, Preschool; Female; Health Personnel; Humans; Infant; Influenza A virus; Influenza B virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Poultry; Pregnancy; Risk Factors; Time Factors | 2005 |
Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Animals; Antiviral Agents; Canada; Child; Child, Preschool; Contraindications; Disease Outbreaks; Drug Resistance, Viral; Female; Health Personnel; Humans; Immunization Schedule; Infant; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Oseltamivir; Poultry; Pregnancy | 2006 |
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Clinical Trials as Topic; Disease Outbreaks; Enzyme Inhibitors; Female; Homes for the Aged; Humans; Immunocompromised Host; Infant; Influenza Vaccines; Influenza, Human; Leukemia; Middle Aged; Nursing Homes; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Rats; Risk; United States; Vaccination; Zanamivir | 2006 |
Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
Topics: Adolescent; Adult; Aged; Animals; Antiviral Agents; Canada; Child; Child, Preschool; Contraindications; Disease Outbreaks; Female; Health Personnel; Humans; Immunization Schedule; Infant; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Poultry; Pregnancy | 2007 |